Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level, European Journal of Cancer, March 2006, Elsevier,
DOI: 10.1016/j.ejca.2005.09.034.
You can read the full text:
Contributors
The following have contributed to this page
